Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

14.08.2017

1 Arch Pathol Lab Med
1 Biochim Biophys Acta
1 BMJ Open
1 Can Urol Assoc J
1 Clujul Med
1 EMBO Rep
1 Int J Biol Macromol
1 Int J Environ Res Public Health
1 Int J Nanomedicine
1 Int J Oncol
1 J Biol Chem
1 J Cell Biochem
1 J Cell Mol Med
1 J Oncol Pract
1 J Surg Oncol
1 Med Phys
1 Mol Carcinog
1 Mol Clin Oncol
1 Nat Rev Urol
1 Onco Targets Ther
3 Oncol Lett
1 Oncol Rep
1 Stat Med
1 Stem Cell Reports
1 Urol Oncol
1 Virol J



    Arch Pathol Lab Med

  1. PARK S, Kang SY, Kwon GY, Kwon JE, et al
    Clinicopathologic Characteristics and Mutational Status of Succinate Dehydrogenase Genes in Paraganglioma of the Urinary Bladder: A Multi-Institutional Korean Study.
    Arch Pathol Lab Med. 2017;141:671-677.
    >> Share


    Biochim Biophys Acta

  2. LV M, Zhong Z, Huang M, Tian Q, et al
    lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
    Biochim Biophys Acta. 2017;1864:1887-1899.
    >> Share


    BMJ Open

  3. HADKHALE K, MacLeod J, Demers PA, Martinsen JI, et al
    Occupational variation in incidence of bladder cancer: a comparison of population-representative cohorts from Nordic countries and Canada.
    BMJ Open. 2017;7:e016538.
    >> Share


    Can Urol Assoc J

  4. FAIREY AS, Jacobsen NE
    Taking it to the HILT: High-intensity local treatment with radical cystectomy for metastatic bladder cancer.
    Can Urol Assoc J. 2017;11:249-250.
    >> Share


    Clujul Med

  5. TRUTA A, Popon TAH, Saraci G, Ghervan L, et al
    Health Related Quality of life in bladder cancer. Current approach and future perspectives.
    Clujul Med. 2017;90:262-267.
    >> Share


    EMBO Rep

  6. LI Y, Zheng F, Xiao X, Xie F, et al
    CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells.
    EMBO Rep. 2017 Aug 9. pii: e201643581. doi: 10.15252/embr.201643581.
    >> Share


    Int J Biol Macromol

  7. MIAO X, Gao H, Liu S, Chen M, et al
    Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells.
    Int J Biol Macromol. 2017 Aug 2. pii: S0141-8130(17)30303.
    >> Share


    Int J Environ Res Public Health

  8. COLLARILE P, Bidoli E, Barbone F, Zanier L, et al
    Residence in Proximity of a Coal-Oil-Fired Thermal Power Plant and Risk of Lung and Bladder Cancer in North-Eastern Italy. A Population-Based Study: 1995-2009.
    Int J Environ Res Public Health. 2017;14.
    >> Share


    Int J Nanomedicine

  9. STAPF M, Teichgraber U, Hilger I
    Methotrexate-coupled nanoparticles and magnetic nanochemothermia for the relapse-free treatment of T24 bladder tumors.
    Int J Nanomedicine. 2017;12:2793-2811.
    >> Share


    Int J Oncol

  10. SUN Y, Guan Z, Zhao W, Jiang Y, et al
    Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-kappaB signal-dependent and signal-independent manner.
    Int J Oncol. 2017 Aug 2. doi: 10.3892/ijo.2017.4089.
    >> Share


    J Biol Chem

  11. JIN H, Xie Q, Guo X, Xu J, et al
    p63alpha protein upregulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion.
    J Biol Chem. 2017 Aug 9. pii: jbc.M117.792010. doi: 10.1074/jbc.M117.792010.
    >> Share


    J Cell Biochem

  12. YAN L, Li Q, Yang J, Qiao B, et al
    TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion and tumor growth of bladder cancer.
    J Cell Biochem. 2017 Aug 11. doi: 10.1002/jcb.26340.
    >> Share


    J Cell Mol Med

  13. XIA J, Zeng M, Zhu H, Chen X, et al
    Emerging role of Hippo signalling pathway in bladder cancer.
    J Cell Mol Med. 2017 Aug 7. doi: 10.1111/jcmm.13293.
    >> Share


    J Oncol Pract

  14. CHANG SS, Bochner BH, Chou R, Dreicer R, et al
    Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary.
    J Oncol Pract. 2017 Aug 10:JOP2017024919. doi: 10.1200/JOP.2017.024919.
    >> Share


    J Surg Oncol

  15. D'ANDREA D, Moschini M, Gust KM, Abufaraj M, et al
    Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy.
    J Surg Oncol. 2017;115:455-461.
    >> Share


    Med Phys

  16. GARAPATI SS, Hadjiiski L, Cha KH, Chan HP, et al
    Urinary Bladder Cancer Staging in CT Urography using Machine Learning.
    Med Phys. 2017 Aug 8. doi: 10.1002/mp.12510.
    >> Share


    Mol Carcinog

  17. CHEN Z, Zhou L, Wang L, Kazobinka G, et al
    HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/beta-catenin signaling.
    Mol Carcinog. 2017 Aug 10. doi: 10.1002/mc.22715.
    >> Share


    Mol Clin Oncol

  18. AVIRMED S, Wang BS, Selenge B, Sanjaajamts A, et al
    Association between MDM2-SNP309 and p53R72P polymorphisms and the risk of bladder cancer in the Mongolian population.
    Mol Clin Oncol. 2017;7:412-420.
    >> Share


    Nat Rev Urol

  19. SIDAWAY P
    Bladder cancer: PPARgamma-RXRalpha alterations promote immune evasion.
    Nat Rev Urol. 2017 Aug 8. doi: 10.1038/nrurol.2017.
    >> Share


    Onco Targets Ther

  20. GAO L, Li SH, Tian YX, Zhu QQ, et al
    Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study.
    Onco Targets Ther. 2017;10:3667-3683.
    >> Share


    Oncol Lett

  21. LI S, Wang F, Zhai Z, Fu S, et al
    Synergistic effect of bladder cancer-specific oncolytic adenovirus in combination with chemotherapy.
    Oncol Lett. 2017;14:2081-2088.
    >> Share

  22. WU H, Hao A, Cui H, Wu W, et al
    TRAF6 expression is associated with poorer prognosis and high recurrence in urothelial bladder cancer.
    Oncol Lett. 2017;14:2432-2438.
    >> Share

  23. KANG HW, Seo SP, Jeong P, Ha YS, et al
    Long-term validation of a molecular progression-associated gene classifier for prediction of muscle invasion in primary non-muscle-invasive bladder cancer.
    Oncol Lett. 2017;14:2468-2474.
    >> Share


    Oncol Rep

  24. GAO SL, Kong CZ, Zhang Z, Li ZL, et al
    TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5883.
    >> Share


    Stat Med

  25. GUHANIYOGI R
    Bayesian nonparametric areal wombling for small-scale maps with an application to urinary bladder cancer data from Connecticut.
    Stat Med. 2017 Aug 7. doi: 10.1002/sim.7408.
    >> Share


    Stem Cell Reports

  26. ZHU F, Qian W, Zhang H, Liang Y, et al
    SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer.
    Stem Cell Reports. 2017;9:429-437.
    >> Share


    Urol Oncol

  27. SIDDIQUI MR, Grant C, Sanford T, Agarwal PK, et al
    Current clinical trials in non-muscle invasive bladder cancer.
    Urol Oncol. 2017;35:516-527.
    >> Share


    Virol J

  28. CAO W, Tian J, Li C, Gao Y, et al
    A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.
    Virol J. 2017;14:149.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016